The advertisement promotes ENTYVIO as a treatment for ulcerative colitis, highlighting its superiority over HUMIRA in clinical remission rates. It includes important safety information and contraindications.
Creative Information
| CID: | 1c5871a9-8c7a-4030-b5fb-27b92c62cea5 |
| CRID: | 82_6854-857441 |
| Domain: | entyviohcp.com |
| Seat: | PP |
| Size: | 300x600 |
| Bid: | $2.27 |
| Timestamp: | 11/7/2025, 2:40:46 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/7/2025, 4:56:41 PM | 7.80s | |
| adomain_analysis | success | 11/7/2025, 6:28:21 PM | 4.24s | |
| adomain_capture | success | 11/7/2025, 6:28:17 PM | 0.11s | |
| ad_render | success | 11/7/2025, 4:56:33 PM | 25.66s | |
| brand_mapping | success | 11/7/2025, 2:40:47 PM | 0.19s | |
Analysis Results
Ad Format: banner
Brands: Entyvio
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x600 | ||||||||||||||||||||||
| Data Transferred: | 1804.58 KB | ||||||||||||||||||||||
| Render Time: | 10.24 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1804.66 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives

